Detail of "121696-62-6"

Reference

Assessment of gastric mucosal damage by a new inclusion complex of piroxicam with b-cyclodextrin: a functional study by a scintigraphic method

Assessment of gastric mucosal damage by a new inclusion complex of piroxicam with b-cyclodextrin: a functional study by a scintigraphic method. Nervetti, A.; Ambanelli, U.; Ugolotti, G. (Fac. Rheumatol., Univ. Parma, Parma, Italy).In this article, certain chemicals are used. Some of their cas registry numbers are 121696-62-6 and 36322-90-4 J. Drug Dev., Suppl., 4(1, b [Beta]-Cyclodextrin-Piroxicam), 39-42 (English) 1991. CODEN: JDDSEP. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) Section cross-reference(s): 1 Scintigraphy was used to assess the effects of b-cyclodextrin-piroxicam and piroxicam with regard to their gastric mucosal damaging potential. The reliability of the new method was demonstrated by comparing scintigraphy and endoscopy with scintigraphy and biopsy. The results of the investigation showed that the incidence of gastric lesions was significantly lower in those patients who received b-cyclodextrin-piroxicam. .